Arch Therapeutics announces $2.5 million registered direct offering
Arch Therapeutics announced agreements with institutional investors for the purchase in a registered direct offering of 14,285,714 shares of its common stock and warrants to purchase up to 14,285,714 shares of icommon stock, at a combined purchase price of $0.175 per share and warrant. October 17, 2019